G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/04/2004	WO2004095022A1 Method of evaluating oxidized protein in horny cell layer
11/04/2004	WO2004095021A1 Method of creating disease prognosis model, method of predicting disease prognosis using the model, device for predicting disease prognosis using the model, its program, and recording medium
11/04/2004	WO2004094996A2 System and method for determining differential protein expression, diagnostic biomarker discovery system and method of using the same, and protein biomarkers and therapeutic and diagnostic uses thereof
11/04/2004	WO2004094992A2 Methods for analysis of biological dataset profiles
11/04/2004	WO2004094989A2 Methods of host cell protein analysis
11/04/2004	WO2004094987A2 Kit for detecting endotoxin in aqueous solutions
11/04/2004	WO2004094986A2 System and method for electrochemical detection of biological compounds
11/04/2004	WO2004094673A2 Methods for monitoring drug activities in vivo
11/04/2004	WO2004094669A1 Arrays comprising biopolymeric test probes for two or more different species and methods for using the same
11/04/2004	WO2004094668A2 Oligonucleotide pairs for multiplexed binding assays
11/04/2004	WO2004094653A2 Differential tag length analysis of cell proliferation
11/04/2004	WO2004094652A2 Zinc-based screening test and kit for early diagnosis of prostate cancer
11/04/2004	WO2004094638A1 Vasculitis antigen and method of diagnosing vasculitis
11/04/2004	WO2004094632A1 Method of detecting histamine-producing bacterium and primer for use in the method
11/04/2004	WO2004094609A2 Methods for characterizing signaling pathways and compounds that interact therewith
11/04/2004	WO2004094604A2 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004	WO2004094603A2 Transgenic mouse with simplified dh locus
11/04/2004	WO2004094602A2 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
11/04/2004	WO2004094600A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
11/04/2004	WO2004094598A2 Methods of use for novel human polypeptides encoded by polynucleotides
11/04/2004	WO2004094594A2 Non-human animal model for graft-versus-host disease
11/04/2004	WO2004094476A2 Compositions and methods relating to stop-1
11/04/2004	WO2004094474A1 Clostridium difficile focussed antibodies
11/04/2004	WO2004094471A2 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004	WO2004094465A2 Synthetic molecules that mimic chemokines
11/04/2004	WO2004094460A2 Polypeptides related to natriuretic peptides and methods of their identification and use
11/04/2004	WO2004094459A2 Polypeptides related to natriuretic peptides and methods of their identification and use
11/04/2004	WO2004094458A2 Major histocompatibility complex (mhc)-peptide arrays
11/04/2004	WO2004094432A1 Porphyrin compound containing biotinyl group and use thereof
11/04/2004	WO2004094408A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists
11/04/2004	WO2004094262A1 Method for noticing changes in a package, method for locating a package, package and system for locating a package
11/04/2004	WO2004094027A2 Microfiltration and/or ultrafiltration process for recovery of target molecules from polydisperse liquids
11/04/2004	WO2004093995A2 Use of antioxidants to treat bone loss disorders
11/04/2004	WO2004093919A2 Target for cancer therapy and drug discovery
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093903A2 Methods and compositions for immunomodulation using cd1 antigens
11/04/2004	WO2004093845A2 Ligand-coupled initiator polymers and methods of use
11/04/2004	WO2004093830A2 Model for neurodegenerative disorders
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004093822A2 Methods for predicting an individual's clinical treatment outcome from sampling a group of patients' biological profiles
11/04/2004	WO2004093808A2 Novel tumor-associated antigens
11/04/2004	WO2004093790A2 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004	WO2004093785A2 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004	WO2004093784A2 Systems and methods for blood glucose sensing
11/04/2004	WO2004093662A2 Method for detecting prognosis of cancer
11/04/2004	WO2004093647A2 Identification and monitoring of systematic lupus erythematosus
11/04/2004	WO2004093646A2 Prognosis, diagnosis and treatment of bone marrow derived stem cell associated cancer
11/04/2004	WO2004093644A2 Methods and apparatus for genetic evaluation
11/04/2004	WO2004093641A2 Acoustic blood analyzer for assessing blood properties
11/04/2004	WO2004093636A2 PLASMA C5a LEVELS AS AN INDICATOR OF ASTHMA SEVERITY
11/04/2004	WO2004086039A8 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof
11/04/2004	WO2004085989A3 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics
11/04/2004	WO2004084808A3 Animal with surgically modified gastrointestinal tract and method for study of weight reduction
11/04/2004	WO2004081536A3 Radical activated cleavage of biologics and microfluidic devices using the same
11/04/2004	WO2004080272A3 Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects
11/04/2004	WO2004080271A3 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
11/04/2004	WO2004077060A3 Assay for detection of renal cell carcinoma
11/04/2004	WO2004074830A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 iii (prostaglandin e2 ep3 iii)
11/04/2004	WO2004074812A3 Library of biphenyl derivatives useful for identifying compounds having both beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/04/2004	WO2004070345A3 Age determination on death
11/04/2004	WO2004069194A3 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes
11/04/2004	WO2004061084A3 Modulation of protein functionalities
11/04/2004	WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004	WO2004059281A3 Analyte detecting article and method
11/04/2004	WO2004058996A3 Method for controlling processes based on microbial interaction
11/04/2004	WO2004055519A3 Specific markers for pancreatic cancer
11/04/2004	WO2004053481A3 Method and installation for determining the end of the cross-linking of a compound comprising reactive synthetic materials
11/04/2004	WO2004048447A3 Controls and standards for assays and method for manufacture thereof
11/04/2004	WO2004047747A3 Compositions and methods for cell dedifferentiation and tissue regeneration
11/04/2004	WO2004047514A3 Methods for identifying risk of breast cancer and treatments thereof
11/04/2004	WO2004043395A3 Methods and compositions for treating neurological disorders
11/04/2004	WO2004043387A3 Compositions and methods for cancer diagnosis and therapy
11/04/2004	WO2004042030A3 Displacement sandwich immuno-pcr
11/04/2004	WO2004039412A3 Compositions for cancer treatment
11/04/2004	WO2004038409A3 Device for measuring the electrical activity of biological elements and its applications
11/04/2004	WO2004033647A3 Assay methods for state-dependent calcium channel agonists/antagonists
11/04/2004	WO2004032841A3 System for production and screening of monoclonal antibodies
11/04/2004	WO2004025251A3 Cell-based detection and differentiation of disease states
11/04/2004	WO2004024173A3 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism
11/04/2004	WO2004019676A3 Animal model for perimenopause and menopause and methods of inducing ovarian failure
11/04/2004	WO2004009540A3 Methods and kits for transferases
11/04/2004	WO2004005884A3 Method and apparatus for molecular mechanics analysis of molecular systems
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2004003550A3 Individualization of therapy with anticoagulants
11/04/2004	WO2004001378A3 Methods for protein analyses and protein expression in multicellular organisms and cells therefrom
11/04/2004	WO2003103662A3 Inhibitors of glycoprotein vi
11/04/2004	WO2003094712A3 System for point of care diagnosis and/or analysis
11/04/2004	WO2003091696A3 Process for identifying and treating specified cell types
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003077851A3 Compounds and methods for analyzing the proteome
11/04/2004	WO2003076593A3 Genomic screen for epigenetically silenced genes associated with cancer
11/04/2004	WO2003066639A3 Methods for identifying targeting domains and methods and compositions comprising the same
11/04/2004	WO2003063784A3 MOLECULES THAT MODULATE GαQ ACTIVITY AND METHODS OF TREATING URINARY INCONTINENCE
11/04/2004	WO2003058201A3 Methods for identifying marker genes for cancer
11/04/2004	WO2003046573A3 Protein biopolymer markers predictive of insulin resistance
11/04/2004	WO2003021226A3 Peptide biomarker and method of identification
11/04/2004	WO2003015716A3 Immunoglobulin e vaccines and methods of use thereof
11/04/2004	WO2003004616A3 Dendritic cell isolation methods
11/04/2004	WO2002086070A3 Binding molecules for fc-region polypeptides
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof

1 ... 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 ... 3937